Get started
Sigyn Therapeutics Inc.Sigyn Therapeutics Inc.Sigyn Therapeutics Inc.

Sigyn Therapeutics Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

SIGY chart

Key stats

Market capitalization
‪7.94 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.82USD
Net income (FY)
‪−4.15 M‬USD
Revenue (FY)
—
Shares float
‪567.88 K‬
Beta (1Y)
−2.60

About Sigyn Therapeutics Inc.

Sector
Health Technology
CEO
James A. Joyce
Headquarters
San Diego
Website
sigyntherapeutics.com
Employees (FY)
5
Founded
2014
FIGI
BBG0099X6C50
Sigyn Therapeutics, Inc. is a development-stage company, which focuses on creating therapeutic solutions that address unmet needs in global health. Its product, Sigyn Therapy, is a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders that are not addressed with approved drug therapies. The company was founded by James A. Joyce and Craig P. Roberts on October 29, 2019 and is headquartered in San Diego, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SIGY is 5.75 USD — it has increased by 4.55% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Sigyn Therapeutics Inc. stocks are traded under the ticker SIGY.
Sigyn Therapeutics Inc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
SIGY stock is 4.35% volatile and has beta coefficient of −2.60. Check out the list of the most volatile stocks — is Sigyn Therapeutics Inc. there?
Yes, you can track Sigyn Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
SIGY stock has fallen by 5.74% compared to the previous week, the month change is a 15.00% rise, over the last year Sigyn Therapeutics Inc. has showed a 11.65% increase.
SIGY net income for the last quarter is ‪−1.18 M‬ USD, while the quarter before that showed ‪−905.73 K‬ USD of net income which accounts for −29.85% change. Track more Sigyn Therapeutics Inc. financial stats to get the full picture.
Today Sigyn Therapeutics Inc. has the market capitalization of ‪7.94 M‬, it has decreased by 8.33% over the last week.
No, SIGY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SIGY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sigyn Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
SIGY reached its all-time high on Oct 18, 2017 with the price of 291045.30 USD, and its all-time low was 2.08 USD and was reached on Jun 20, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 5.00 employees. See our rating of the largest employees — is Sigyn Therapeutics Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sigyn Therapeutics Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sigyn Therapeutics Inc. stock shows the sell signal. See more of Sigyn Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.